Stay updated on ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Sign up to get notified when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.

Latest updates to the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page shows Revision: v3.6.3 in place of Revision: v3.6.2, indicating a small software update applied to the page rather than a change to the study data or details.SummaryDifference0.0%

- Check17 days agoChange DetectedA new revision tag Revision: v3.6.2 was added and the previous tag Revision: v3.6.0 was removed. This reflects a newer site release and does not alter study content or user-facing information.SummaryDifference0.0%

- Check31 days agoChange DetectedThe study page now indicates recruitment is closed for participants, and several help/navigation items were added along with a revision/version note updating from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check38 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4, indicating a new version of the page content. This change reflects an update to the page’s version label rather than any visible content modification.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, signaling a minor release of the page. This update does not alter the study’s data or displayed information.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page footer version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/update release rather than a change to the clinical trial information presented.SummaryDifference0.0%

Stay in the know with updates to ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Enter your email address, and we'll notify you when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.